Methylene Blue Liquid
$44.99
In stockMethylene blue, also known as methylthioninium chloride, is a synthetic compound with oxidation-reduction, or redox, activity—meaning it can accept and donate electrons. It has established medical applications and has also been investigated for its effects on brain function and cellular energy metabolism.
| SKU | RC-RR-MBLUE-LIQ |
|---|---|
| Manufacturer | R+R Innovations |
| Form | Tincture (Liquid) |
| Strength | 10 mg |
| Size | 30 mL |
| Reported Result | Supplier spec pending verification |
| Stock | In stock |
| Documentation Status | Pending Final COA |
Product Description
Methylene blue, also known as methylthioninium chloride, is a synthetic compound with oxidation-reduction, or redox, activity—meaning it can accept and donate electrons. It has established medical applications and has also been investigated for its effects on brain function and cellular energy metabolism.
Interest in methylene blue’s potential cognitive effects comes partly from research involving mitochondrial respiration, the processes cells use to generate energy. These effects depend on concentration and experimental conditions.
What research has shown:
An established, specific medical use: FDA-approved intravenous methylene blue treats acquired methemoglobinemia, a condition that impairs the blood’s ability to carry oxygen. This approval does not extend to general wellness or cognitive-enhancement products.
Preliminary memory findings: A randomized, double-blind study involving 26 healthy adults reported a 7% increase in correct responses during a memory-retrieval task after oral methylene blue. This small, single-administration study does not establish lasting improvements in everyday memory.
Changes in brain activity: The same study found changes in functional MRI responses during attention and short-term-memory tasks. Brain-imaging changes are research findings rather than proof of broadly improved cognition.
Methylene blue has important medication interactions. It can cause serious or fatal serotonin syndrome when combined with serotonergic medications, including certain antidepressants and opioids. It can also cause severe red-blood-cell breakdown in people with G6PD deficiency. Its established medical use should not be interpreted as evidence that unsupervised wellness use is safe.
Storage and handling: Keep sealed, dry, and protected from heat and direct light unless the final product label or COA states otherwise. Maintain the product with its matching batch record.
Third-party testing status.
| Batch / Lot | Reported Result | Tested | Partner | Status | Document |
|---|---|---|---|---|---|
| RC-RA-METHYLENEBLU-09-0526 | Supplier spec pending verification | Pending | Pending | Pending Final COA | Pending Final COA |
.png)